Inventor
GRAHAM PARRY
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C07KPeptides27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C12YEnzymes10%
A01NPreservation of bodies of humans or animals or plants or parts thereof3%
C12NMicroorganisms or enzymes3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
PatentTitleYear
12,391,750Anti-C1S antibodies and methods of use thereof202512,240,917Anti-complement C1s antibodies and uses thereof202512,215,169Anti-complement C1s antibodies and uses thereof202511,999,780Humanized anti-complement factor Bb antibodies and uses thereof202411,851,482Anti-complement factor Bb antibodies and uses thereof202311,246,926Polynucleotides encoding anti-C1s antibodies202211,242,382Humanized anti-complement factor Bb antibodies202211,192,944Methods of inducing complement activity2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to BIOVERATIV USA INC (6)· patent assignee history
2021–2025Based in US· patent location history
2022–2024Patents assigned to GENZYME CORP (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOVERATIV USA INC | 6 | 2021–2025 |
| GENZYME CORP | 3 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2021–2025 |